| Model Number |
0684-00-0295-05 |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
01/25/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Due to character restrictions in block e1.Event site name: (b)(6).Event site address line 2: (b)(6).The device has not been returned to the manufacturer so we are unable to complete an evaluation.If provided, we will send a supplemental report with our additional findings.Complaint id: (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that intra-aortic balloon(iab) first, after implanting a 50cc balloon, the patient was prompted that there was blood in the balloon.After removing it, it was confirmed that there was blood inside the balloon.During the implantation process, it was found that the central cavity of the balloon was folded and could not be successfully implanted into the blood vessel.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated fields: h6 (type of investigation, investigation findings, component codes, investigation conclusions).No decon or visual inspection performed since product was not returned and could not be evaluated.Therefore, we were unable to confirm or determine a root cause for the reported failure.The failure mode is addressed in the risk file and is operating within its risk profile.The ifu addresses the reported failure.There were no ncmrs identified which could cause or contribute to the reported failure.The investigation does not indicate that the device was inadvertently released as non-conforming or an adulterated product or was a counterfeit.The complaint history review did not identify an adverse trend (increase in number of complaints over past three (3) months).Based on the rational provided above, no escalation to the capa process is required.Complaint id: (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that intra-aortic balloon(iab) first, after implanting a 50cc balloon, the patient was prompted that there was blood in the balloon.After removing it, it was confirmed that there was blood inside the balloon.During the implantation process, it was found that the central cavity of the balloon was folded and could not be successfully implanted into the blood vessel.There was no injury or harm reported to the patient.
|
| |
|
Event or Problem Description
|
|
N/a.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated fields: b4, d9, g1(contact person ¿ mfg site), g3, g6, h2, h3, h6 (type of investigation, investigation findings, component codes), h11.The iab was returned with the membrane completely unfolded and traces of blood on the exterior of the catheter.No blood was observed inside the iab catheter.The extender tubing and insertion components were also returned.The pressure tubing was returned unused.An underwater leak test of the balloon, catheter, y-fitting, extracorporeal and extender tubing was performed and no leaks were detected.The reported event cannot be confirmed by the evaluation.A lot history record review was completed for the reported product.No nonconformances were found that are considered to be related to the event.The failure mode is addressed in the risk file and is operating within its risk profile.The ifu addresses the reported failure.There were no ncmrs identified which could cause or contribute to the reported failure.The investigation does not indicate that the device was inadvertently released as non-conforming or an adulterated product or was a counterfeit.The complaint history review did not identify an adverse trend (increase in number of complaints over past three (3) months).Based on the rational provided above, no escalation to the capa process is required.The reported event cannot be confirmed by the evaluation.
|
| |
|
Search Alerts/Recalls
|